Physician profile
Michael K Barron
NPI 1912999038
$1,843.96
in general payments reported to CMS, 2019-2025
18 companies · $98.40 in 2025
The $98.40 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $374 · 2021: $625 · 2022: $373 · 2023: $8.15 · 2024: $161 · 2025: $98.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $392.00 | 2019-2020 | |
| Medtronic, INC. | $331.91 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $183.35 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $177.56 | 2019-2025 | Lifevest |
| Baxter Healthcare | $125.00 | 2022 | |
| Amgen INC. | $123.70 | 2024 | Repatha |
| Boston Scientific Corporation | $84.44 | 2019-2022 | |
| Abbott Laboratories | $81.45 | 2021 | |
| Novartis Pharmaceuticals Corporation | $80.09 | 2021-2025 | |
| Pfizer INC. | $57.09 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $56.82 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $32.91 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.21 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.87 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $20.08 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $19.57 | 2022 | |
| Livanova USA, INC. | $12.76 | 2021 | |
| Medicomp INC | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.